Researchers have created an AI tool that uses CT imaging to predict the spread risk of oropharyngeal cancer, offering improved treatment stratification.
Key Details
- 1Developed and validated by Mass General Brigham and Dana-Farber Cancer Institute.
- 2AI tool predicts likelihood of lymph node extranodal extension (ENE) using CT scans.
- 3Tested on imaging data from 1,733 patients with oropharyngeal carcinoma.
- 4Integration of AI assessment improved risk stratification for survival and cancer spread.
- 5Could guide both escalation and de-escalation of treatment strategies.
- 6Published in Journal of Clinical Oncology (DOI: 10.1200/JCO-24-02679).
Why It Matters
This tool offers a noninvasive approach for more accurate prognosis and tailored therapies in head and neck cancer, potentially reducing unnecessary interventions and improving outcomes. It demonstrates a significant advance in leveraging imaging AI for complex cancer management decisions.
Source
EurekAlert
Related News
•EurekAlert
Review Finds AI Model Architecture Key for Brain Tumor MRI Segmentation
A systematic review highlights that AI model architecture, more than data or imaging specifics, drives improved tumor segmentation in brain MRI scans.
•EurekAlert
Mount Sinai to Showcase AI Innovations in Lung and Sleep Imaging at ATS 2026
Mount Sinai experts will present new research on AI and imaging for lung nodules, sleep apnea, and cardiovascular risk at the ATS 2026 Conference.
•EurekAlert
AI Doctor Avatars Boost Cancer Patient Understanding Before Radiology Consults
Meeting an AI avatar doctor before consultations helps cancer patients understand treatment better and reduces stress.